Filing Details

Accession Number:
0001104659-15-013142
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-02-23 21:39:59
Reporting Period:
2015-02-19
Filing Date:
2015-02-23
Accepted Time:
2015-02-23 21:39:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1600132 Bellerophon Therapeutics Inc. BLPH Pharmaceutical Preparations (2834) 473116175
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1280564 Martin Meglasson C/O Bellerophon Therapeutics, Inc.
53 Frontage Road, Suite 301
Hampton NJ 08827
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-02-19 12,000 $12.00 18,386 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct